📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-21 16:51
0 analysed today
FollowTelegram
0
Today
151,853
All-time analysed
43,533
Positive
6,742
Negative
92,741
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
5 announcements match the current filters (relevance ≥ 5).
Stellant Securities Revises Preferential Issue to ₹77.61 Cr via EGM Corrigendum
Stellant Securities has issued a corrigendum to its August 24, 2026 EGM notice to adjust its proposed preferential issue. Following the disqualification of two proposed allottees under SEBI ICDR regulations due to prior share sales, the issue size stands revised to 12,89,177 shares at ₹602 per share, aggregating to ₹77.61 crore. The company clarified its object of issue, intending to deploy 98% of proceeds into listed equities/warrants within 6 months and 2% into hiring research personnel.
Confidence: HIGH
What changedRemoved two ineligible allottees from the proposed preferential issue and detailed the explicit percentage allocation and timeline for fund utilization.
Why it mattersA ₹77.61 Cr capital injection represents a massive balance sheet expansion compared to the company's nominal historical revenue base, shifting its operating scale toward active portfolio investments.
Total Issue Size: Rs. 77,60,84,554/-Number of Equity Shares: 12,89,177Issue Price per Share: Rs. 602/-Equity Investment Allocation: 98%Deployment Timeline: 6 months
📅 Short termShareholders will vote on the revised preferential allotment resolutions at the EGM on August 24, 2026.
📈 Long termSuccessful fundraise and deployment of ₹77.61 Cr into listed equities will significantly alter the company's financial asset base and investment earnings profile.
⚠ Risk flags
- SEBI ICDR compliance disqualifications among proposed allottees
- High exposure to public equity market volatility with 98% of funds allocated to market securities
- Substantial equity dilution relative to existing share capital
Key Highlights
Preferential issue adjusted to 12,89,177 equity shares aggregating to ₹77,60,84,554 (₹77.61 Cr)
Issue price set at ₹602 per share, comprising ₹10 face value and ₹592 premium
98% of proceeds earmarked for investment in listed equity shares/warrants within 6 months
Two allottees disqualified and removed under Regulation 159(1) of SEBI ICDR Regulations due to share sales
👀 What to Watch
Track the shareholder voting results at the EGM on August 24, 2026, followed by in-principle listing approvals and subsequent capital deployment announcements.
Stellant Securities to raise •99.2 Cr via preferential issue; EGM on Aug 24
Stellant Securities (India) Ltd has scheduled an Extraordinary General Meeting (EGM) for August 24, 2026, to seek shareholder approval for a significant capital infusion of approximately •99.2 crore. The company plans to issue 3,48,837 warrants to promoters and 12,99,143 equity shares to public investors, both at a fixed price of •602 per unit. To facilitate this, the authorized share capital is proposed to be increased from •7 crore to •17 crore. This fundraise is highly material given the company's current TTM revenue is near zero.
Confidence: HIGH
What changedThe company is transitioning from a low-activity entity to raising nearly •100 crore in fresh capital through a preferential allotment to both promoters and public investors.
Why it mattersThe fundraise represents approximately 10% of the current market capitalization and is massive compared to the company's zero TTM revenue, suggesting a potential shift in business strategy or upcoming acquisitions.
Total Fundraise: •99.2 CrIssue Price: •602Fundraise vs Market Cap: ~9.9%New Authorized Capital: •17 CrEGM Date: 24 August 2026
📅 Short termThe stock may see volatility as the market reacts to the •602 issue price, which is close to the current market price of •624.
📈 Long termThe long-term outlook depends entirely on the management's ability to deploy the •99 crore into revenue-generating assets, given the current lack of business operations.
⚠ Risk flags
- Significant equity dilution
- Negligible current revenue (TTM •0 Cr)
- Extremely high P/E valuation (12479.0)
Key Highlights
Total proposed fundraise of •99.2 crore through equity and warrants
Issuance of 3,48,837 warrants to promoters at •602 each, totaling •21 crore
Issuance of 12,99,143 equity shares to public investors at •602 each, totaling •78.2 crore
Authorized share capital to be increased by 142% from •7 crore to •17 crore
Relevant date for determining the issue price set as July 24, 2026
👀 What to Watch
Monitor the EGM voting results on August 24 and watch for subsequent filings regarding the specific intended use of these funds, as the company currently has no significant operations.
₹99.21 Cr Fundraise via Preferential Issue of Shares and Warrants at ₹602 per Unit
Stellant Securities has approved a significant capital infusion of ₹99.21 Cr through a preferential issue. The company will issue 12.99 lakh equity shares to 50 public investors for ₹78.21 Cr and 3.49 lakh warrants to promoters for ₹21 Cr. Both instruments are priced at ₹602, which is a slight premium to the current market price of ₹594.4. To facilitate this, the authorized share capital is being increased from ₹7 Cr to ₹17 Cr.
Confidence: HIGH
What changedThe company is transitioning from a dormant financial state (₹0 TTM revenue) to a capitalized entity with nearly ₹100 Cr in fresh capital.
Why it mattersThis fundraise represents approximately 10.4% of the current market cap and is highly material for a company with no current operations, suggesting a potential major business pivot or acquisition.
Total Fundraise: ₹99.21 CrFundraise vs Market Cap: 10.43%Issue Price: ₹602New Authorized Capital: ₹17 CrWarrant Conversion Period: 18 months
📅 Short termThe stock may see positive sentiment as the issue price is higher than the current market price and involves promoter participation.
📈 Long termThe long-term outlook depends entirely on the deployment of the ₹99 Cr; the company currently lacks a functional business model based on TTM financials.
⚠ Risk flags
- Significant equity dilution
- Extremely high valuation (P/E > 11,000)
- Lack of operational track record (₹0 TTM revenue)
Key Highlights
Total fundraise of ₹99.21 Cr through equity shares and convertible warrants
Issue price of ₹602 per share represents a premium over the current market price of ₹594.4
Authorized share capital increased by 142.8% from ₹7 Cr to ₹17 Cr
Promoter group to inject ₹21 Cr via warrants with 25% (₹5.25 Cr) payable upfront
50 public category investors, including Lloyds Enterprises Ltd, to participate in the ₹78.21 Cr equity issue
👀 What to Watch
Monitor the upcoming shareholder meeting for approval and watch for any announcements regarding the specific utilization of these funds, given the company's current zero-revenue status.
₹10 Cr Increase in Authorized Capital and Preferential Issue Proposed by Stellant Securities
Stellant Securities (India) Ltd has scheduled a board meeting on July 24, 2026, to consider a preferential issue of securities for fundraising. The company proposes to increase its Authorized Share Capital by 143%, from ₹7 crore to ₹17 crore. This is a significant move for a company with a market capitalization of ₹926 crore but negligible TTM revenue (₹0 Cr). The trading window for designated persons will be closed from July 21, 2026, until 48 hours after the meeting.
Confidence: HIGH
What changedThe company is initiating a process to significantly expand its capital base and raise fresh funds through a preferential allotment.
Why it mattersGiven the company's current lack of operational revenue and extremely high valuation, a fundraise could indicate a potential business pivot or capital infusion for new operations, though it also implies equity dilution.
Current Authorized Capital: ₹7,00,00,000Proposed Authorized Capital: ₹17,00,00,000Increase in Capital: ₹10,00,00,000Market Cap: ₹926 CrTTM Revenue: ₹0 Cr
📅 Short termThe stock may experience volatility leading up to and following the July 24 board meeting as details of the fundraise are disclosed.
📈 Long termThe long-term outlook depends entirely on the company's ability to utilize the raised capital to generate sustainable revenue, which has been absent in recent periods.
⚠ Risk flags
- Significant equity dilution risk
- Extremely high valuation (P/E > 11,000)
- Lack of operational revenue (TTM ₹0 Cr)
- Recent decline in promoter holding from 65.44% to 43.76%
Key Highlights
Board meeting scheduled for July 24, 2026, to approve a preferential issue of securities.
Proposed increase in Authorized Share Capital from ₹7,00,00,000 to ₹17,00,00,000.
Authorized capital to be expanded to 1,70,00,000 equity shares of ₹10 each.
Trading window closure for designated persons starting July 21, 2026.
Company currently reports TTM revenue of ₹0 Cr and a P/E ratio of 11,575.
👀 What to Watch
Investors should monitor the July 24 board meeting outcome for the specific fundraise amount, the issue price, and the identity of the preferential allottees to understand the company's future direction.
Rs 3.82 Cr Infusion: Stellant Securities Allots 1.5 Lakh Shares to Promoter via Warrant Conversion
Stellant Securities (India) Ltd has allotted 1,50,000 equity shares to its promoter, Mangala Subhash Rathod, following the conversion of warrants. The conversion was executed at an issue price of Rs. 340 per share (including a Rs. 330 premium), bringing in Rs. 3.825 crore as the final 75% payment. This transaction increases the total paid-up equity capital to 56,85,995 shares. Consequently, the specific promoter's individual stake has increased from 18.84% to 20.44%.
Confidence: HIGH
What changedThe company converted 50% of its previously issued 3,00,000 warrants into equity shares, resulting in a capital infusion and a change in the promoter's shareholding percentage.
Why it mattersThis represents a direct cash infusion into the company and signals promoter confidence, as the shares were issued at a significant premium (33x face value).
Issue Price per Share: Rs. 340Shares Allotted: 1,50,000Funds Received (75% balance): Rs. 3,82,50,000Post-Allotment Promoter Stake: 20.44%New Paid-up Capital: Rs. 5,68,59,950
📅 Short termThe news is likely to be viewed positively by the market due to the promoter increasing their stake and the immediate capital infusion.
📈 Long termThe additional capital strengthens the balance sheet; however, long-term value depends on the company's ability to generate returns on this new equity capital.
⚠ Risk flags
- Equity dilution for non-promoter shareholders
- Concentration of ownership in promoter hands
Key Highlights
Allotment of 1,50,000 equity shares at a total issue price of Rs. 340 per share
Receipt of Rs. 3,82,50,000 representing the balance 75% payment for the warrants
Promoter Mangala Subhash Rathod's stake increased from 18.84% to 20.44%
Total paid-up capital expanded from Rs. 5.53 crore to Rs. 5.68 crore
Conversion stems from a preferential allotment of 3,00,000 warrants originally made on February 02, 2026
👀 What to Watch
Investors should monitor the company's upcoming financial statements to see how the Rs. 3.82 crore in fresh capital is deployed and track the status of the remaining 1,50,000 warrants yet to be converted.
